Loading...
U.S. Physical Therapy, Inc.
USPH•NYSE
Healthcare
Medical - Care Facilities
$75.03
$-0.61(-0.81%)
U.S. Physical Therapy, Inc. (USPH) Financial Performance & Income Statement Overview
Review U.S. Physical Therapy, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-7.32%
↓ 7.32%
Operating Income Growth
-9.12%
↓ 9.12%
Net Income Growth
80.32%
↑ 80.32%
Operating Cash Flow Growth
-8.59%
↓ 8.59%
Operating Margin
10.26%
↑ 10.26%
Gross Margin
18.80%
↑ 18.80%
Net Profit Margin
4.45%
↑ 4.45%
ROE
6.09%
↑ 6.09%
ROIC
6.49%
↑ 6.49%
U.S. Physical Therapy, Inc. (USPH) Income Statement & Financial Overview
Review U.S. Physical Therapy, Inc.'s (USPH) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $180.45M | $168.03M | $167.19M | $155.68M |
Cost of Revenue | $147.92M | $138.90M | $136.13M | $125.65M |
Gross Profit | $32.53M | $29.13M | $31.07M | $30.03M |
Gross Profit Ratio | $0.18 | $0.17 | $0.19 | $0.19 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $17.99M | $16.11M | $11.45M | $15.71M |
Operating Expenses | $17.99M | $14.38M | $11.45M | $15.71M |
Total Costs & Expenses | $135.52M | $153.29M | $147.58M | $141.36M |
Interest Income | $306000.00 | $1.02M | $1.07M | $1.54M |
Interest Expense | $2.05M | $2.02M | $1.98M | $1.97M |
Depreciation & Amortization | $5.68M | $4.39M | $4.51M | $4.09M |
EBITDA | $26.06M | $18.74M | $21.29M | $20.82M |
EBITDA Ratio | $0.14 | $0.11 | $0.13 | $0.13 |
Operating Income | $14.54M | $14.75M | $19.61M | $14.32M |
Operating Income Ratio | $0.08 | $0.09 | $0.12 | $0.09 |
Other Income/Expenses (Net) | $3.78M | -$2.41M | -$4.82M | $440000.00 |
Income Before Tax | $18.32M | $12.34M | $14.79M | $14.76M |
Income Before Tax Ratio | $0.10 | $0.07 | $0.09 | $0.09 |
Income Tax Expense | $5.83M | $2.56M | $3.08M | $3.14M |
Net Income | $7.44M | $5.53M | $6.88M | $6.61M |
Net Income Ratio | $0.04 | $0.03 | $0.04 | $0.04 |
EPS | $0.46 | $0.39 | $0.47 | $0.46 |
Diluted EPS | $0.46 | $0.39 | $0.47 | $0.46 |
Weighted Avg Shares Outstanding | $15.09M | $15.08M | $15.07M | $15.02M |
Weighted Avg Shares Outstanding (Diluted) | $15.09M | $15.08M | $15.07M | $15.02M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan